Graft engineering sees potential to reduce GVHD risk in leukemia patients
New study shows risk of developing graft-versus-host disease (GVHD) in leukaemia patients reduced by removing naïve T cells from donor blood used for stem cell grafts.
List view / Grid view
New study shows risk of developing graft-versus-host disease (GVHD) in leukaemia patients reduced by removing naïve T cells from donor blood used for stem cell grafts.
Researchers have shown that using mobile vans to deliver and dispense HIV drugs in South Africa and Uganda helps to combat the disease.
The experimental male birth control pill 11-beta-MNTDC - a modified testosterone that has the combined actions of a male hormone and a progesterone - passes human safety tests...
A drug used to treat rheumatoid arthritis improves survival after hematopoietic stem cell transplant...